Business

Santhera Publishes Agenda for its Annual General Meeting

Pratteln, Switzerland, April 29, 2025 – Santhera Pharmaceuticals (SIX: SANN) today published the invitation to its Annual General Meeting (AGM), which will be held on May 20, 2025, at 10:00 CEST at Haus der Wirtschaft, Hardstrasse 1, 4133 Pratteln, Switzerland. The invitation to the AGM with agenda items and explanations will be sent to registered shareholders by mail and can be viewed on Santhera’s website at www.santhera.com/investors-and-media/investor-toolbox/share-bondholder-meetings Agenda

Santhera Pharmaceuticals Holding AgApril 29, 20253
Santhera Publishes Agenda for its Annual General Meeting

About this update from Santhera Pharmaceuticals Holding Ag

Pratteln, Switzerland, April 29, 2025 – Santhera Pharmaceuticals (SIX: SANN) today published the invitation to its Annual General Meeting (AGM), which will be held on May 20, 2025, at 10:00 CEST at Haus der Wirtschaft, Hardstrasse 1, 4133 Pratteln, Switzerland. The invitation to the AGM with agenda items and explanations will be sent to registered shareholders by mail and can be viewed on Santhera’s website at www.santhera.com/investors-and-media/investor-toolbox/share-bondholder-meetings Agenda (Overview)

View stock analysis, news, and events for Santhera Pharmaceuticals Holding Ag

Annual General MeetingPratteln, SwitzerlandConsolidated Financial StatementsCompensation ReportCompensation CommitteeSantheraHaus der Wirtschaftthe Board of DirectorsExecutive ManagementArticles of Incorporation

More from Santhera Pharmaceuticals Holding Ag

Santhera Expands Biomedica Agreement to Extend AGAMREE® (Vamorolone) Distribution Across Central Asia and the Caucasus

July 13, 2026

Santhera Announces Orphan Drug and Priority Review Designations for AGAMREE® (Vamorolone) in South Korea

June 2, 2026

All Santhera Pharmaceuticals Holding Ag news →